Share on StockTwits

RPX Corp. (NASDAQ:RPXC) Director Geoffrey T. Barker sold 10,000 shares of the stock on the open market in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $15.09, for a total value of $150,900.00. Following the transaction, the director now directly owns 289,399 shares of the company’s stock, valued at approximately $4,367,031. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

RPX Corp. (NASDAQ:RPXC) traded down 0.33% during mid-day trading on Friday, hitting $14.96. 391,815 shares of the company’s stock traded hands. RPX Corp. has a 1-year low of $14.55 and a 1-year high of $18.75. The stock has a 50-day moving average of $16.32 and a 200-day moving average of $16.35. The company has a market cap of $803.7 million and a P/E ratio of 23.75.

RPX Corp. (NASDAQ:RPXC) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.24 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.22 by $0.02. The company had revenue of $64.30 million for the quarter, compared to the consensus estimate of $63.72 million. During the same quarter last year, the company posted $0.26 earnings per share. RPX Corp.’s revenue was up 16.9% compared to the same quarter last year. Analysts expect that RPX Corp. will post $0.97 earnings per share for the current fiscal year.

RPXC has been the subject of a number of recent research reports. Analysts at Barclays downgraded shares of RPX Corp. from an “overweight” rating to an “equal weight” rating in a research note on Monday, August 4th. They now have a $17.00 price target on the stock, down previously from $20.00. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of RPX Corp. in a research note on Monday, July 21st. They now have a $19.00 price target on the stock, up previously from $18.50.

RPX Corporation (NASDAQ:RPXC) provides patent risk management solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.